Efficient repeated low-dose intravaginal infection with X4 and R5 SHIVs in rhesus macaque: Implications for HIV-1 transmission in humans

Virology

Volumn 362, Issue 1, 2007, Pages 207-216

  Tsai, Lily ^a   Trunova, Nataliya ^a   Gettie, Agegnehu ^a   Mohri, Hiroshi ^a   Bohm, Rudolf ^b   Saifuddin, Mohammed ^c   Cheng Mayer, Cecilia ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^c EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Dose effect; SHIV; Vaginal transmission

Indexed keywords

ARTICLE; BOTTLENECK POPULATION; GENETIC HETEROGENEITY; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VAGINITIS; VIRUS INFECTION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ANIMALS; CD4 LYMPHOCYTE COUNT; DISEASE MODELS, ANIMAL; FEMALE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MACACA MULATTA; MUCOUS MEMBRANE; RNA, VIRAL; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VAGINA; VARIATION (GENETICS); VIRAL LOAD; VIREMIA; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; MACACA MULATTA; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 34247198954     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.12.024     Document Type: Article

References (41)

1. Boadi T., Schneider E., Chung S., Tsai L., Gettie A., Ratterree M., Blanchard J., Neurath A.R., and Cheng-Mayer C. Cellulose acetate 1,2-benzenedicarboxylate protects against challenge with pathogenic X4 and R5 simian/human immunodeficiency virus. AIDS 19 15 (2005) 1587-1594
2. Brandt S.M., Mariani R., Holland A.U., Hope T.J., and Landau N.R. Association of chemokine-mediated block to HIV entry with coreceptor internalization. J. Biol. Chem. 277 19 (2002) 17291-17299
3. Charpentier C., Nora T., Tenaillon O., Clavel F., and Hance A.J. Extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients. J. Virol. 80 5 (2006) 2472-2482
4. Chen Z., Telfier P., Gettie A., Reed P., Zhang L., Ho D.D., and Marx P.A. Genetic characterization of new West African simian immunodeficiency virus SIVsm: geographic clustering of household-derived SIV strains with human immunodeficiency virus type 2 subtypes and genetically diverse viruses from a single feral sooty mangabey troop. J. Virol. 70 6 (1996) 3617-3627
5. Coffin J.M. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267 5197 (1995) 483-489
6. Davenport M.P., Zhang L., Shiver J.W., Casmiro D.R., Ribeiro R.M., and Perelson A.S. Influence of peak viral load on the extent of CD4+ T-cell depletion in simian HIV infection. J. Acquired Immune Defic. Syndr. 41 3 (2006) 259-265
7. DeGruttola V., Seage III G.R., Mayer K.H., and Horsburgh Jr. C.R. Infectiousness of HIV between male homosexual partners. J. Clin. Epidemiol. 42 9 (1989) 849-856
8. Delwart E.L., Shpaer E.G., Louwagie J., McCutchan F.E., Grez M., Rubsamen-Waigmann H., and Mullins J.I. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science 262 5137 (1993) 1257-1261
9. Frater A.J., Edwards C.T., McCarthy N., Fox J., Brown H., Milicic A., Mackie N., Pillay T., Drijfhout J.W., Dustan S., Clarke J.R., Holmes E.C., Zhang H.T., Pfafferott K., Goulder P.J., McClure M.O., Weber J., Phillips R.E., and Fidler S. Passive sexual transmission of human immunodeficiency virus type 1 variants and adaptation in new hosts. J. Virol. 80 14 (2006) 7226-7234
10. Galvin S.R., and Cohen M.S. The role of sexually transmitted diseases in HIV transmission. Nat. Rev., Microbiol. 2 1 (2004) 33-42
11. Garcia P.M., Kalish L.A., Pitt J., Minkoff H., Quinn T.C., Burchett S.K., Kornegay J., Jackson B., Moye J., Hanson C., Zorrilla C., and Lew J.F. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N. Engl. J. Med. 341 6 (1999) 394-402
12. Gray R.H., Wawer M.J., Brookmeyer R., Sewankambo N.K., Serwadda D., Wabwire-Mangen F., Lutalo T., Li X., vanCott T., and Quinn T.C. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 357 9263 (2001) 1149-1153
13. Gray R.H., Li X., Wawer M.J., Gange S.J., Serwadda D., Sewankambo N.K., Moore R., Wabwire-Mangen F., Lutalo T., and Quinn T.C. Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda. AIDS 17 13 (2003) 1941-1951
14. Greenier J.L., Miller C.J., Lu D., Dailey P.J., Lu F.X., Kunstman K.J., Wolinsky S.M., and Marthas M.L. Route of simian immunodeficiency virus inoculation determines the complexity but not the identity of viral variant populations that infect rhesus macaques. J. Virol. 75 8 (2001) 3753-3765
15. Harouse J.M., Gettie A., Eshetu T., Tan R.C., Bohm R., Blanchard J., Baskin G., and Cheng-Mayer C. Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3). J. Virol. 75 4 (2001) 1990-1995
16. Harouse J.M., Buckner C., Gettie A., Fuller R., Bohm R., Blanchard J., and Cheng-Mayer C. CD8+ T cell-mediated CXC chemokine receptor 4-simian/human immunodeficiency virus suppression in dually infected rhesus macaques. Proc. Natl. Acad. Sci. U. S. A. 100 19 (2003) 10977-10982
17. Hendrickx A.G., and Cukierski M.A. Reproductive and developmental toxicology in nonhuman primates. Prog. Clin. Biol. Res. 235 (1987) 73-88
18. Jeanmougin F., Thompson J.D., Gouy M., Higgins D.G., and Gibson T.J. Multiple sequence alignment with Clustal X. Trends Biochem. Sci. 23 10 (1998) 403-405
19. Jewell N.P., and Shiboski S.C. Statistical analysis of HIV infectivity based on partner studies. Biometrics 46 4 (1990) 1133-1150
20. Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J. Mol. Evol. 16 2 (1980) 111-120
21. Koot M., Keet I.P., Vos A.H., de Goede R.E., Roos M.T., Coutinho R.A., Miedema F., Schellekens P.T., and Tersmette M. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann. Intern. Med. 118 9 (1993) 681-688
22. Lori F., Hall L., Lusso P., Popovic M., Markham P., Franchini G., and Reitz Jr. M.S. Effect of reciprocal complementation of two defective human immunodeficiency virus type 1 (HIV-1) molecular clones on HIV-1 cell tropism and virulence. J. Virol. 66 9 (1992) 5553-5560
23. Luciw P.A., Mandell C.P., Himathongkham S., Li J., Low T.A., Schmidt K.A., Shaw K.E., and Cheng-Mayer C. Fatal immunopathogenesis by SIV/HIV-1 (SHIV) containing a variant form of the HIV-1SF33 env gene in juvenile and newborn rhesus macaques. Virology 263 1 (1999) 112-127
24. Ma Z.M., Abel K., Rourke T., Wang Y., and Miller C.J. A period of transient viremia and occult infection precedes persistent viremia and antiviral immune responses during multiple low-dose intravaginal simian immunodeficiency virus inoculations. J. Virol. 78 24 (2004) 14048-14052
25. Mansfield K.G., Lerch N.W., Gardner M.B., and Lackner A.A. Origins of simian immunodeficiency virus infection in macaques at the New England Regional Primate Research Center. J. Med. Primatol. vol. 24 (1995) 116-122
26. McDermott A.B., Mitchen J., Piaskowski S., De Souza I., Yant L.J., Stephany J., Furlott J., and Watkins D.I. Repeated low-dose mucosal simian immunodeficiency virus SIVmac239 challenge results in the same viral and immunological kinetics as high-dose challenge: a model for the evaluation of vaccine efficacy in nonhuman primates. J. Virol. 78 6 (2004) 3140-3144
27. Mellors J.W., Kingsley L.A., Rinaldo Jr. C.R., Todd J.A., Hoo B.S., Kokka R.P., and Gupta P. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 122 8 (1995) 573-579
28. Mellors J.W., Rinaldo Jr. C.R., Gupta P., White R.M., Todd J.A., and Kingsley L.A. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272 5265 (1996) 1167-1170
29. Miller C.J. Mucosal transmission of simian immunodeficiency virus. Curr. Top. Microbiol. Immunol. 188 (1994) 107-122
30. Miller C.J., and Lu F.X. Anti-HIV and -SIV immunity in the vagina. Int. Rev. Immunol. 22 1 (2003) 65-76
31. Miller C.J., Marthas M., Greenier J., Lu D., Dailey P.J., and Lu Y. In vivo replication capacity rather than in vitro macrophage tropism predicts efficiency of vaginal transmission of simian immunodeficiency virus or simian/human immunodeficiency virus in rhesus macaques. J. Virol. 72 4 (1998) 3248-3258
32. Moore J.P., Kitchen S.G., Pugach P., and Zack J.A. The CCR5 and CXCR4 coreceptors-central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. AIDS Res. Hum. Retroviruses 20 1 (2004) 111-126
33. Muller H.J. The relation of recombination to mutational advance. Mutat. Res. 106 (1964) 2-9
34. Neildez O., Le Grand R., Caufour P., Vaslin B., Cheret A., Matheux F., Theodoro F., Roques P., and Dormont D. Selective quasispecies transmission after systemic or mucosal exposure of macaques to simian immunodeficiency virus. Virology 243 1 (1998) 12-20
35. Pilcher C.D., Tien H.C., Eron Jr. J.J., Vernazza P.L., Leu S.Y., Stewart P.W., Goh L.E., and Cohen M.S. Brief but efficient: acute HIV infection and the sexual transmission of HIV. J. Infect. Dis. 189 10 (2004) 1785-1792
36. Quinn T.C., Wawer M.J., Sewankambo N., Serwadda D., Li C., Wabwire-Mangen F., Meehan M.O., Lutalo T., and Gray R.H. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N. Engl. J. Med. 342 13 (2000) 921-929
37. Shattock R.J., and Moore J.P. Inhibiting sexual transmission of HIV-1 infection. Nat. Rev., Microbiol. 1 1 (2003) 25-34
38. UNAIDS/WHO AIDS Epidemic Update: December 2005. Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO) (2005).
39. Wawer M.J., Gray R.H., Sewankambo N.K., Serwadda D., Li X., Laeyendecker O., Kiwanuka N., Kigozi G., Kiddugavu M., Lutalo T., Nalugoda F., Wabwire-Mangen F., Meehan M.P., and Quinn T.C. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J. Infect. Dis. 191 9 (2005) 1403-1409
40. Wick D., and Self S.G. Early HIV infection in vivo: branching-process model for studying timing of immune responses and drug therapy. Math. Biosci. 165 2 (2000) 115-134
41. Zhu T., Mo H., Wang N., Nam D.S., Cao Y., Koup R.A., and Ho D.D. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 261 5125 (1993) 1179-1181